[Immunomodulatory properties of subtherapeutic levels of theophylline].
Chorostowska-Wynimko
J
J
Zakładu Immunologii Instytutu Gruźlicy i Chorób Płuc w Warszawie.
D000276:Adjuvants, Immunologic; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D015703:Antigens, CD / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology*; D016516:CD4-CD8 Ratio / Q000187:drug effects; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage; D013806:Theophylline / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D015703:Antigens, CD; D010726:Phosphodiesterase Inhibitors; D013806:Theophylline
Immunomodulacyjne właściwości subterapeutycznych stezeń teofiliny.